Abstract
BackgroundAs treatments for rheumatoid arthritis (RA) such as methotrexate (MTX) and biological agents have made dramatic progress in this decade, it is desirable to improve patient quality of life and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
